System and method for responding to pulsed gradient magnetic fields using an implantable medical device

• US 7,369,898 B1
• Filed: 12/22/2004
• Issued: 05/06/2008
• Est. Priority Date: 12/22/2004
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Shkurovich, Sergio, Dalal, Nirav, Kroll, Mark W., Bornzin, Gene A.
• Primary Examiner(s): Winakur; Eric
• Assistant Examiner(s): BOR, HELENE CATHERINE
• Application Number:
  US11/020,438
• Time in Patent Office: 1,231 Days
• Field of Search: 600/410, 600/411, 607/30, 607/27, 607/63
• US Class Current: 607/63
• CPC Class Codes: A61B 5/055 involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
• CPC Class Codes: A61N 1/36514 controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by two or more physical parameters A61N1/36585
• CPC Class Codes: A61N 1/3688 configured for switching the pacing mode, e.g. from AAI to DDD
• CPC Class Codes: A61N 1/37 Monitoring; Protecting
• CPC Class Codes: A61N 1/3718 Monitoring of or protection against external electromagnetic fields or currents

Abstract

Implantable medical devices, such as pacemakers or implantable cardioverter defibrillators (ICDs), are vulnerable to the powerful magnetic fields associated with magnetic resonance imaging (MRI). In particular, pulsed gradient components, if strong enough, can induce parasitic currents that may damage the device or cause parasitic pacing that may trigger an arrhythmia in the patient. The static magnetic field components of the MRI typically do not induce parasitic currents, even though they may be as strong as the pulsed gradient components. Accordingly, techniques are described herein for specifically addressing the pulsed gradient components of the MRI fields so as to reduce the risk of parasitic currents. In one example, a pacemaker switches to tri-state pacing outputs in the presence of strong pulsed gradient magnetic fields. The device continues with normal bi-state pacing outputs so long as the pulsed gradient fields are not strong, even in the presence of a strong static magnetic field. As an added safety feature, the pacemaker switches to fixed-rate ventricular pacing whenever strong static MRI fields are detected.

Claims

1. In an implantable medical device, a method comprising:

operating in a first pacing mode to deliver pacing therapy using a first set of device outputs and a first pacing vector defined by a first pair of electrodes;

detecting magnetic fields;

detecting for static component of the magnetic fields and if any are detected, determining a value representative of the strength of the static component and comparing the static component value to a static magnetic field threshold;

detecting for pulsed gradient components of the magnetic fields and if any are detected, determining a value representative of the strength of the pulsed gradient components and comparing the pulsed gradient component value to a pulsed gradient threshold; and

controlling device functions differently based on whether both the static component value and the pulse gradient component value exceed their respective threshold, only one of the static component value and the pulse gradient component value exceed their respective threshold, and neither of the static component value and the pulse gradient component value exceed their respective threshold.

2. The method of claim 1 wherein the value representative of a strength of the pulsed gradient components is the mean of |dB/dt|.

3. The method of claim 1 wherein detecting for pulsed gradient components of the magnetic fields comprises measuring a value representative of a strength of the pulsed gradient components along a predetermined axis.

4. The method of claim 3 wherein the value representative of a strength of the pulsed gradient components along a predetermined axis is the mean of |dB_i/dt| where “

i”

represents the predetermined axis.

5. The method of claim 1 wherein the pacing mode is any mode other than fixed rate ventricular pacing (VOO) and the first set of device outputs are bi-state pacing outputs and when both the static component value and the pulse gradient component value exceed their respective threshold, further comprising switching the pacing made to VOO and the device outputs to tri-state pacing outputs.

6. The method of claim 5 further comprising switching the pacing vector to a second vector defined by a second pair of electrodes different from the first pair of electrodes.

7. The method of claim 6 wherein the first pair of electrodes are RV tip and an RV ring electrodes and wherein the second pair of electrodes are RV tip and device housing electrodes.

8. The method of claim 1 wherein the pacing mode is any mode other than fixed rate ventricular pacing (VOO) and the first set of device outputs are bi-state pacing outputs and when only the static component value exceeds its threshold, further comprising switching the device outputs to tri-state outputs.

9. The method of claim 8 further comprising switching the pacing vector to a second vector defined by a second pair of electrodes different from the first pair of electrodes.

10. The method of claim 8 further comprising maintaining the pacing mode.

11. The method of claim 1 wherein the pacing mode is any mode other than fixed rate ventricular pacing (VOO) and the first set of device outputs are bi-state pacing outputs and when only the pulse gradient component value exceeds its threshold, further comprising switching the pacing mode.

12. The method of claim 11 further comprising maintaining the device outputs as bi-state pacing outputs.

13. The method of claim 1 wherein the pacing mode is any mode other than fixed rate ventricular pacing (VOO) and the first set of device outputs are bi-state pacing outputs and when neither of the static component value and the pulse gradient component value exceed their respective threshold, further comprising maintaining the pacing mode and the bi-state pacing outputs.

14. An implantable medical device comprising:

means for operating in a first pacing mode to deliver pacing therapy using a first set of device outputs and a first pacing vector defined by a first pair of electrodes means for detecting magnetic fields;

means for detecting for static component of the magnetic fields and if any are detected, determining a value representative of the strength of the static component and comparing the static component value to a static magnetic field threshold;

means for detecting for pulsed gradient components of the magnetic fields and if any are detected, determining a value representative of the strength of the pulsed gradient components and comparing the pulsed gradient component value to a pulsed gradient threshold; and

means for controlling device functions differently based on whether both the static component value and the pulse gradient component value exceed their respective threshold, only one of the static component value and the pulse gradient component value exceed their respective threshold, and neither of the static component value and the pulse gradient component value exceed their respective threshold.

15. In an implantable cardiac stimulation device having a voltage generator for applying a voltage across a first electrode and a second electrode for pacing the heart of a patient, a method comprising:

detecting magnetic fields associated with magnetic resonance imaging (MRI);

detecting a strength of pulsed gradient components of the magnetic fields; and

if the strength of the pulsed gradient components of the magnetic field is above a predetermined parasitic current risk threshold level, establishing current paths between the voltage generator and first and second electrodes only during pace pulse delivery, otherwise opening the current path between the voltage generator and one of the first and second electrodes.